DSM and Sanquin sign manufacturing agreement for factor IX antibody

10/24/2013 | Genetic Engineering & Biotechnology News

Sanquin Blood Supply Foundation and DSM Pharmaceutical Products have signed a commercial manufacturing agreement to produce a monoclonal antibody for the recovery and purification of coagulation factor IX from human blood. Production will take place at a DSM Biologics facility in the Netherlands.

View Full Article in:

Genetic Engineering & Biotechnology News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
In house Compliance Officer
Confidential
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC